Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Stony Brook Hospital and Medical Center
mi
from
Stony Brook, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Stony Brook Hospital and Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital Health Center
mi
from
Syracuse, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital Health Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center- North East
mi
from
Charlotte, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center- North East
mi
from
Charlotte, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Presbyterian Hospital
mi
from
Charlotte, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Presbyterian Hospital
mi
from
Charlotte, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center - Pineville
mi
from
Charlotte, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center - Pineville
mi
from
Charlotte, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Wake Med
mi
from
Raleigh, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Wake Med
mi
from
Raleigh, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Aultman Hospital
mi
from
Canton, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Aultman Hospital
mi
from
Canton, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
The Christ Hospital
mi
from
Cincinnati, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Mercy St. Vincent Medical Center
mi
from
Toledo, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Genesis - Good Samaritan Hospital
mi
from
Zanesville, OH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Integris Baptist Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence St. Vincent Medical Center
mi
from
Portland, OR
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence St. Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sacred Heart Medical Center
mi
from
Springfield, OR
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sacred Heart Medical Center
mi
from
Springfield, OR
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Bryn Mawr
mi
from
Bryn Mawr, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Bryn Mawr
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Holy Spirit Hospital
mi
from
Camp Hill, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Holy Spirit Hospital
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Doylestown Hospital
mi
from
Doylestown, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Pinnacle Health @ Harrisburg Hospital
mi
from
Harrisburg, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health @ Harrisburg Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
West Shore Hospital
mi
from
Harrisburg, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
West Shore Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Alleghany General Hospital
mi
from
Pittsburgh, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Alleghany General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
UPMC
mi
from
Pittsburgh, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Joseph Medical Center
mi
from
Reading, PA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Joseph Medical Center
mi
from
Reading, PA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Miriam Hospital
mi
from
Providence, RI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
AnMed Health
mi
from
Anderson, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
AnMed Health
mi
from
Anderson, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Hospital
mi
from
Columbia, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Hospital
mi
from
Columbia, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Greenville Memorial Hospital
mi
from
Greenville, SC
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Greenville Memorial Hospital
mi
from
Greenville, SC
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Wellmont Holston Valley Medical Center
mi
from
Kingsport, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Northwest Texas Healthcare System
mi
from
Amarillo, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Seton Medical Center Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Harrison Methodist
mi
from
Fort Worth, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Harrison Methodist
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Methodist Hospital
mi
from
Houston, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Carilion Roanoke Memorial Hospital
mi
from
Roanoke, VA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Providence Everett Medical Center
mi
from
Everett, WA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Providence Everett Medical Center
mi
from
Everett, WA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Liverpool Hospital
mi
from
Liverpool,
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Liverpool Hospital
mi
from
Liverpool,
Click here to add this to my saved trials